한빛사논문
- 조회1,930
Galam Leem1, Junsik Park2, Minwoo Jeon1, Eui-Soon Kim1, Sang Wun Kim2, Yong Jae Lee2, Seong Jin Choi1, Baekgyu Choi3, Seongyeol Park1, Young Seok Ju1, Inkyung Jung3, Sunghoon Kim2, Eui-Cheol Shin1, Jung Yun Lee2,* and Su-Hyung Park1,*
1Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
2Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Republic of Korea
3Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
*Correspondence to Dr Su-Hyung Park; Dr Jung Yun Lee;
GL and JP are joint first authors.
Abstract
Background
Responses to immunotherapy vary between different cancer types and sites. Here, we aimed to investigate features of exhaustion and activation in tumor-infiltrating CD8 T cells at both the primary and metastatic sites in epithelial ovarian cancer.
Methods
Tumor tissues and peripheral blood were obtained from 65 patients with ovarian cancer. From these samples, we isolated tumor-infiltrating lymphocytes (TILs) and peripheral blood mononuclear cells. These cells were used for immunophenotype using multicolor flow cytometry, gene expression profile using RNA sequencing and ex vivo functional restoration assays.
Results
We found that CD39+ CD8 TILs were enriched with tumor-specific CD8 TILs, and that the activation status of these cells was determined by the differential programmed cell death protein 1 (PD-1) expression level. CD39+ CD8 TILs with high PD-1 expression (PD-1high) exhibited features of highly tumor-reactive and terminally exhausted phenotypes. Notably, PD-1high CD39+ CD8 TILs showed similar characteristics in terms of T-cell exhaustion and activation between the primary and metastatic sites. Among co-stimulatory receptors, 4-1BB was exclusively overexpressed in CD39+ CD8 TILs, especially on PD-1high cells, and 4-1BB-expressing cells displayed immunophenotypes indicating higher degrees of T-cell activation and proliferation, and less exhaustion, compared with cells not expressing 4-1BB. Importantly, 4-1BB agonistic antibodies further enhanced the anti-PD-1-mediated reinvigoration of exhausted CD8 TILs from both primary and metastatic sites.
Conclusion
Severely exhausted PD-1high CD39+ CD8 TILs displayed a distinctly heterogeneous exhaustion and activation status determined by differential 4-1BB expression levels, providing rationale and evidence for immunotherapies targeting co-stimulatory receptor 4-1BB in ovarian cancers.
논문정보
- Research article
- 2020년 12월 (BRIC 등록일 2020-12-30)
- 국내 연구진
- 의약학 > 면역의학
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
관련분야 논문보기
